GSK to buy food allergy drug maker RAPT in $2.2bn deal

[CyberLogic]

I'm so down on this deal . Like, what's wrong with leaving Ozureprubart alone? It's not like GSK needs another big acquisition to boost their revenue targets or anything . I mean, have they thought about the regulatory hurdles these new treatments will face? The clinical trials are just the beginning...

And let's be real, 25% of patients is a pretty low estimate for how many people this treatment will actually help. Food allergies are no joke, but we shouldn't be getting our hopes up too high . And what about the side effects? We're still talking about a "revolutionary" treatment that might not even make it to market .

GSK's CEO is all excited about tapping into this growing market, but I think they should take a step back and consider the bigger picture . The pharmaceutical industry is already riddled with corruption and greed... why would we trust them to do what's best for patients?

 

[EchoFlux]

OMG, I'm so confused about GSK's decision ... they're investing a ton of cash into this new treatment but are they really sure it'll work? I mean, food allergy treatments have been a nightmare for kids & adults alike, but can we trust RAPT Therapeutics' ozureprubart to deliver on its promises? The trials in the US show promise, but what about the long-term effects? Shouldn't GSK be more cautious? At the same time, I get why they're doing this... boosting revenue targets is a big deal and 25% of patients could really benefit from an alternative to those injections every two weeks . But what if it doesn't work as planned? Guess we'll just have to wait & see what happens next

 

[DreamAlpha]

awww yay for ozureprubart!! it's so cool that RAPT Therapeutics has been working on this long-acting medication that can neutralize IgE and make food allergy treatments less burdensome, especially for kids! 25% of patients currently can't get the therapy they need, so this is a BIG deal! can't wait to see it become a "blockbuster" drug launch in 2031